SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 3 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,949,806 | +4.6% | 552,300 | -1.2% | 0.75% | +5.8% |
| Q2 2023 | $64,005,228 | +944.0% | 558,900 | +1156.5% | 0.71% | +648.4% |
| Q1 2023 | $6,130,541 | +147.8% | 44,479 | +133.0% | 0.10% | +120.9% |
| Q4 2022 | $2,473,682 | -4.9% | 19,090 | -18.9% | 0.04% | -10.4% |
| Q3 2022 | $2,602,000 | -69.5% | 23,539 | -79.3% | 0.05% | -66.4% |
| Q2 2022 | $8,520,000 | +76.6% | 113,660 | +84.0% | 0.14% | +155.4% |
| Q1 2022 | $4,825,000 | +935.4% | 61,759 | +929.8% | 0.06% | +700.0% |
| Q2 2021 | $466,000 | -94.7% | 5,997 | -88.5% | 0.01% | -94.9% |
| Q4 2020 | $8,863,000 | +201.3% | 51,986 | +168.5% | 0.14% | +29.0% |
| Q2 2019 | $2,942,000 | -7.3% | 19,359 | -27.3% | 0.11% | -34.0% |
| Q1 2019 | $3,174,000 | -47.2% | 26,626 | -28.5% | 0.16% | -57.6% |
| Q3 2018 | $6,011,000 | -53.2% | 37,216 | -61.7% | 0.38% | -42.6% |
| Q2 2018 | $12,841,000 | – | 97,145 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |